Medtronic Says FDA OKs Expanded Indication for Cardiac Resynchronization Therapy

Medtronic said the FDA approved an expanded indication for its cardiac resynchronization therapy with implantable cardioverter defibrillator, or CRT-D, devices.
RTTnews